John Ziebuhr

Professor

Justus Liebig University

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Giuliano Ciarimboli

University Hospital Münster

GERMANY

View details

Dieter Glebe

Justus Liebig University

GERMANY

View details

Francisco Medrano

Centro de Investigaciones Biológicas Margarita Salas

SPAIN

View details

Alexander Gorbalenya

Professor

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Jonel Trebicka

GERMANY

View details

Joachim Geyer

Full Professor, Head of Department

Justus Liebig University

GERMANY

View details

M. Lienhard Schmitz

Full Professor

University of Giessen

GERMANY

View details

Elke Roeb

Justus Liebig University

GERMANY

View details

Heiko Slanina

Justus Liebig University

GERMANY

View details

Sergio Martí

Profesor Titular de Universidad

Universitat Jaume I

SPAIN

View details

Annabelle Carolin Weldert

Johannes Gutenberg Universität Mainz

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Ziebuhr

Research Interests

Explore related searches

Contact this professor

Articles (12)

Alpha- and betacoronavirus cis-acting RNA elements.

Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2

Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape

Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity

Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit

Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs

Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics

Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection

Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.

Collaborators (11)

Giuliano Ciarimboli

Dieter Glebe

Francisco Medrano

Alexander Gorbalenya

Jonel Trebicka

Joachim Geyer

M. Lienhard Schmitz

Elke Roeb

Heiko Slanina

Sergio Martí

Annabelle Carolin Weldert

Make your next move.